Skip to main content
. 2011 Oct 11;73(4):579–587. doi: 10.1111/j.1365-2125.2011.04114.x

Figure 3.

Figure 3

Mean urine excretion rate at the end time of the collection interval and mean tolvaptan plasma concentration vs. time following a single oral 240 mg dose of tolvaptan alone (A) or with rifampicin at steady-state (B) to 15 healthy subjects. Urine excretion rate (Inline graphic); Tolvaptan Concentration (Inline graphic)